In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
George L. Bakris, MD, FAHA, FASN, faculty for this educational event, has received consulting fees from Bayer, KBP Biosciences, Ionis, Alnylam, Astra Zeneca, Quantum Genomics, Horizon, Novo Nordisk, Dia Medica Therapeutics, and InREGEN.
Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA, faculty for this educational event, has received consulting fees from Amgen, Novartis, Medtronic, Eli Lilly, and Quantum Genomics.
Sreekanth Vemulapalli, MD, chair and faculty for this educational event, received consulting fees from American College of Physicians, Edwards Lifesciences, and Medtronic; received research funding from Cytokinetics, Abbott Vascular, Boston Scientific, American College of Cardiology, Society of Thoracic Surgeons.
Raven Voora, MD, faculty for this educational event, has received consulting fees from Medtronic.